An Epidemic of Mucormycosis Coinciding With the COVID-19 Pandemic in India
Asia Pac J Public Health
.
2022 Mar;34(2-3):304-305.
doi: 10.1177/10105395211058828.
Epub 2021 Nov 13.
Authors
ArunSundar MohanaSundaram
1
,
Shanmugarajan Thukani Sathanantham
2
,
Abhijit Kulkarni
3
4
5
,
Shweta Kulkarni
6
,
Vijay Chinchole
7
8
9
,
Bhushan Patil
8
9
,
Ravichandiran Velayutham
10
Affiliations
1
School of Pharmacy, Sathyabama Institute of Science and Technology, Chennai, India.
2
School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies, Chennai, India.
3
Apollo Hospital, Navi Mumbai, India.
4
SRV Mamata Hospital, Dombivli, India.
5
Aditya Brain and Spine Clinic, Dombivli, India.
6
Vedh Eye Hospital, Dombivli, India.
7
Manobal Neuropsychiatric Clinic, Dombivli, India.
8
MannSparsh Neuropsychiatric Hospital, Kalyan, India.
9
Manasa Rehabilitation & De-Addiction Center, Titwala, India.
10
National Institute of Pharmaceutical Education and Research, Kolkata, India.
PMID:
34779277
DOI:
10.1177/10105395211058828
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
India / epidemiology
Mucormycosis* / epidemiology
Pandemics
SARS-CoV-2